The Effect of Hypoxia Therapy on the State If External Respiration in Patients with COVID-19

Introduction: Post-recovery rehabilitation patients face ongoing COVID-19 impacts on their pulmonary function as a major clinical issue. The ongoing respiratory problems which affect lung capacity and ventilation efficiency demonstrate why specific therapeutic approaches are essential. Research indicates that hypoxytherapy which involves controlled intermittent hypoxia exposure shows potential benefits for pulmonary adaptation and respiratory function recovery. The research assesses how hypoxytherapy affects major respiratory indicators in patients recovering from COVID-19. Objective: To assess the impact of hypoxytherapy on pathogenetic and functional parameters of the upper respiratory tract in individuals recovering from COVID-19. Materials and Methods: The research included three separate groups: (1) a control group of healthy participants and (2) post-COVID-19 patients who received no treatment and (3) post-COVID-19 patients who received hypoxytherapy treatment. The pulmonary function was assessed through spirometric tests which measured forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and maximum lung ventilation (MVL). Results: The patients who received hypoxytherapy treatment showed better respiratory outcomes than those who did not receive treatment after COVID-19. The FVC and FEV1 values increased by an average of X% and Y% respectively, which shows that lung capacity and expiratory efficiency improved. The peak inspiratory capacity (PIC) also increased by Z%, which indicates that pulmonary function improved overall. The results indicate that hypoxytherapy helps patients recover from respiratory problems by optimizing oxygen use and lung adaptation. Conclusion: The results indicate that hypoxytherapy could be an effective rehabilitation method for patients with post-COVID-19 respiratory dysfunction which may lead to improved recovery and better pulmonary function. The observed benefits support the recommendation of incorporating hypoxytherapy into post-COVID-19 rehabilitation protocols especially for patients with ongoing respiratory impairment. Additional large-scale clinical research needs to be conducted to optimize treatment protocols and evaluate long-term effects and general patient population applicability.